Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pulmonx Corp Director's Dealing 2021

Jun 12, 2021

34428_dirs_2021-06-11_1c33d6f9-0e02-49fd-b444-1261c270dfef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-06-01

Reporting Person: Mead Dana G Jr. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-01 Common Stock A 2810 $0.00 Acquired 29125 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4076 Indirect

Footnotes

F1: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021.

F2: The shares received as a liquidation distribution from KPCB XIII Associates, LLC, the managing member of Kleiner Perkins Caufield & Byers XIII, LLC, the direct holder of the shares as disclosed in prior reports.

F3: The shares are held directly by the Dana G. Mead, Jr. And D'Arcy Gage Mead, or Their Successors, as Trustees of The Mead Family Trust Created Uta Dated August 4, 1998, as Amended.